HEMATOLOGIJA
Economic Outcomes
slovenščina
Economic Outcomes
/assets/ct/79e1b14fff/images/syn_placeholder_sqr.png

Hematologija

Economic Outcomes

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (odpre novo okno)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn, DR

Vir‎: Anaesthesia 2019;74(12):1534-41.

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (odpre novo okno)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Vir‎: Blood Adv. 2022;6(3):785-92.